-
Marijuana Capital Markets: Bright 2025 Outlook Amid Regulatory Shifts
Monday, November 4, 2024 - 2:05pm | 861The cannabis capital markets are getting ready for what could be their most transformative period. With the 2024 election cycle underway, changes in the regulatory landscape could significantly boost investor confidence and support the industry's growth in 2025. As MJBiz Daily reported, although...
-
Almost Every Major Cannabis Company Could See Positive Cash Flow If 280E Is Removed In 2025
Monday, October 14, 2024 - 1:53pm | 815A recent analysis of 14 multi-state cannabis operators (MSOs) looks at how the potential removal of 280E in 2025 could impact their cash flows. Section 280E of the U.S. tax code, which prevents cannabis companies from deducting normal business expenses due to federal prohibition, has long been a...
-
Federal Overreach Vs. State Rights: Can Cannabis Businesses Gain Independence?
Friday, October 11, 2024 - 4:11pm | 660At the recent Benzinga Cannabis Capital Conference in Chicago (Oct. 8 and 9), Emily Paxhia, founding partner and managing partner of Poseidon Investment Management, shared her thoughts on one of the most pressing legal battles facing the cannabis industry. Speaking shortly after her panel, Paxhia...
-
EXCLUSIVE: Cannabis Companies Must 'Get More Juice From The Same Squeeze,' Says Cresco Labs CEO As Challenges Persist
Wednesday, October 9, 2024 - 3:05pm | 806Finding a balance between getting more scale, but still being productive and having high margins in the current landscape in the cannabis industry, is a "daily challenge." That's according to Charlie Bachtell, CEO and co-founder of Cresco Labs Inc (OTCQX:CRLBF), a company running over 70 cannabis...
-
EXCLUSIVE: Weed Companies Will Be Treated Like Normal Businesses Once This Tax Provision Goes Away, Experts Say
Tuesday, October 8, 2024 - 2:48pm | 824Marijuana companies would be "treated like normal businesses," if the oppressive restrictions of Section 280E of the Internal Revenue Code, which prevents cannabis businesses from deducting typical business expenses, go away. That's according to Darren Weiss, president of Verano Holdings Corp. (...
-
Cannabis Rescheduling Could Boost Profits By 25% If Federal Tax Rules Change, Says Expert
Tuesday, August 27, 2024 - 11:33am | 494With federal cannabis rescheduling possibly on the horizon, industry leaders are analyzing the potential impacts this regulatory shift could have on the financial landscape of cannabis businesses. Experts have weighed in on the potential implications of rescheduling, particularly concerning access...
-
Will Federal Policy Changes Finally Free Cannabis Businesses From Tax Burdens?
Monday, July 22, 2024 - 10:46am | 542As the cannabis industry awaits potential federal policy changes, Beau Whitney, founder and chief economist at Whitney Economics, shares his analysis of how these reforms could reshape its financial future. His observations come ahead of the Benzinga Cannabis Capital Conference this October, where...
-
End Of IRS' 280E On The Horizon? What Cannabis Rescheduling Means For Business Tax Deductions
Saturday, July 6, 2024 - 11:21am | 739The cannabis industry may be on the verge of significant financial relief with the Biden administration's proposal to reclassify cannabis to Schedule III of the Controlled Substances Act. This reclassification would eliminate the oppressive restrictions of Section 280E of the Internal Revenue Code...
-
Are The Illicit Market, Curaleaf And Trulieve The 3 Biggest Winners From Rescheduling Cannabis?
Saturday, May 25, 2024 - 3:22pm | 1336This article was originally published on Cannabis.net and appears here with permission. President Joe Biden's support of the administration's decision to reschedule cannabis from Schedule I to Schedule III is likely to result in considerable financial benefits for large, legal cannabis...
-
Former FDA Agent Says Big Pharma Not Likely To Get Involved In Cannabis Industry After Rescheduling
Friday, May 3, 2024 - 9:24am | 862Three national leaders gathered Wednesday to discuss the impact of the Drug Enforcement Administration's historic move to reclassify cannabis as a less dangerous drug. Removing marijuana from Schedule 1 – the same class as heroin, LSD, meth and ecstasy – to Schedule III along with...
-
New Tax Rules In Cannabis: What Are The Consequences DEA Rescheduling?
Thursday, May 2, 2024 - 4:09pm | 797In a significant shift for the cannabis industry, marijuana is set to be reclassified as a Schedule 3 controlled substance. While this change does not address the ongoing federal prohibition, removal of the 280E IRS tax code will have substantial consequences for the cannabis space, particularly...
-
Beating The IRS Tax Code: A Cannabis Company's Successful ESOPs Transition To Empower Workers And Unlock Growth
Tuesday, April 16, 2024 - 7:30pm | 559MBO Ventures, a leading investment bank specializing in Employee Stock Ownership Plans (ESOPs) within the cannabis sector, has completed an ESOP for Canna Provisions. This award-winning, woman-led cannabis retailer and cultivator in Massachusetts, has been recognized for its quality products...
-
Top Cannabis Diversification Secrets: Industry Leaders Reveal Strategies For Success At Benzinga Conference
Tuesday, April 16, 2024 - 4:38pm | 713One of the most discussed concepts in the cannabis industry is diversification—a strategy discussed in depth during a panel on the first day of the Benzinga Cannabis Capital Conference in Florida. Moderated by Amy Rubenstein, partner at Dentons, the panel gathered industry experts to dissect...
-
Cannabis Industry Facing High Cost Challenges As Tax Day Approaches
Tuesday, April 2, 2024 - 4:49pm | 788As the tax filing deadline of April 15 approaches, it's intriguing to examine the fiscal challenges and structural injustices faced by the cannabis industry. That's why we've prepared some back-of-the-envelope calculations: The cannabis sector has contributed significantly to states...
-
Cannabis Businesses Face Tax Dilemma: A Closer Look At IRS Roadblock
Monday, March 25, 2024 - 10:39am | 739The cannabis industry is currently navigating a significant financial obstacle due to the IRS’s Section 280E, a tax provision that places a heavy burden on legal cannabis operations. Matt Hawkins, founder and managing partner of Entourage Effect Capital and upcoming speaker at Benzinga...